Amneal Pharmaceuticals Of New York, LLC FDA Record
- Latest inspection NAI · Feb 3, 2020
- 2 Class I recalls
- No warning letters matched by name
Amneal Pharmaceuticals Of New York, LLC has 27 FDA recalls (2 Class I), 11 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Amneal Pharmaceuticals Of New York, LLC" is on file.
- Latest recall
- D-0873-2026 · Sep 8, 2026 · filed under Amneal Pharmaceuticals
- Latest recall under this name
- D-0868-2026 · Class II · Aug 28, 2026
- Latest inspection
- Feb 3, 2020 · NAI
Newer recall under related name Amneal Pharmaceuticals: Sep 8, 2026, D-0873-2026.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 27 (2 Class I) | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 11 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Amneal Pharmaceuticals Of New York, LLC: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 1 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 4 | 1 |
| 2023 | 0 | 0 | 0 | 4 | 0 |
| 2022 | 0 | 0 | 0 | 1 | 0 |
| 2021 | 0 | 0 | 0 | 2 | 0 |
| 2020 | 1 | 0 | 0 | 13 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 1 | 1 |
Reviewing Amneal Pharmaceuticals Of New York, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Amneal Pharmaceuticals Of New York, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0868-2026 | Class II | Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For… | Aug 28, 2026 |
| D-0477-2024 | Class II | Methylergonovine Maleate Tablets, USP, 0.2mg, 12-count bottle, Rx Only, Distributed by: Amneal… | Mar 25, 2024 |
| D-0442-2024 | Class I | Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC… | Mar 21, 2024 |
| D-0327-2024 | Class II | Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed… | Feb 13, 2024 |
| D-0319-2024 | Class II | Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by… | Jan 15, 2024 |
| D-0426-2024 | Class II | Divalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by… | Dec 26, 2023 |
| D-0090-2024 | Class II | Extended Phenytoin Sodium Capsules, USP, 100 mg, 100-count bottle, Distributed by Amneal… | Oct 27, 2023 |
| D-0876-2023 | Class II | Extended Phenytoin Sodium Capsules, USP, 100 mg, Rx Only, 100 capsules per bottle, Distributed by… | May 30, 2023 |
| D-0756-2023 | Class III | Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and… | May 8, 2023 |
| D-1362-2022 | Class II | Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only… | Jul 27, 2022 |
| D-0233-2022 | Class II | Flocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by… | Nov 4, 2021 |
| D-0234-2022 | Class II | Flocinolone Acetonide 0.01% Topical Oil, Scalp Oil, Rx, packaged in 4 oz. bottle, Distributed by… | Nov 4, 2021 |
| D-1348-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg Rx only 100 Tablets bottles… | May 29, 2020 |
| D-1350-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Distributed by: Amneal… | May 29, 2020 |
| D-1352-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles… | May 29, 2020 |
| D-1393-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 90 count bottle, Rx Only… | May 29, 2020 |
| D-1343-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, Rx Only, 100 count bottles… | May 29, 2020 |
| D-1353-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000 tablets bottles… | May 29, 2020 |
| D-1354-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, USP, Bulk, Rx Only, Distributed by: Amneal… | May 29, 2020 |
| D-1351-2020 | Class II | amneal Metformin Hydrochloride Extended-Release Tablets, 500 mg USP, 500 tablets bottles, Rx only… | May 29, 2020 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 3, 2020 | Hauppauge, NY | Drugs | No Action Indicated (NAI) | 2434153 |
| Mar 18, 2019 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| Apr 11, 2017 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| Aug 9, 2016 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| Mar 16, 2015 | Hauppauge, NY | Drugs | No Action Indicated (NAI) | 2434153 |
| Feb 7, 2014 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| May 15, 2012 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| Oct 29, 2010 | Hauppauge, NY | Drugs | No Action Indicated (NAI) | 2434153 |
| May 26, 2010 | Hauppauge, NY | Drugs | No Action Indicated (NAI) | 2434153 |
| Nov 24, 2009 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
| Aug 18, 2009 | Hauppauge, NY | Drugs | Voluntary Action Indicated (VAI) | 2434153 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 2434153 | Hauppauge, NY | 11 | Feb 3, 2020 |
Amneal Pharmaceuticals Of New York, LLC and the FDA: common questions
Has Amneal Pharmaceuticals Of New York, LLC received an FDA warning letter?
No FDA warning letter addressed to the name "Amneal Pharmaceuticals Of New York, LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Amneal Pharmaceuticals Of New York, LLC received an FDA Form 483?
FDA has not published a Form 483 for "Amneal Pharmaceuticals Of New York, LLC" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Amneal Pharmaceuticals Of New York, LLC?
The most recent FDA inspection on file ended Feb 3, 2020 at Hauppauge, NY and was classified NAI. FDA has 11 inspections of Amneal Pharmaceuticals Of New York, LLC on file.
Has Amneal Pharmaceuticals Of New York, LLC had an FDA recall?
Yes. Amneal Pharmaceuticals Of New York, LLC has 27 FDA recalls on record, 2 of them Class I, the most serious class. The most recent under this name started Aug 28, 2026. A newer recall, dated Sep 8, 2026, is filed under the related name Amneal Pharmaceuticals.
Need more than this page shows? Ask about Amneal Pharmaceuticals Of New York, LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.